New Data for Phase 2 Study of UBX1325

David Xu, MD, and Michael A. Singer, MD

Show Description +

David Xu, MD, asks Michael A. Singer, MD, about new 24-week data from the phase 2 ENVISION trial of UBX1325, a senolytic agent for patients with wet AMD.

Posted: 5/08/2023

Keywords:

#retina-meeting-recaps

Up Next

Name: New Data for Phase 2 Study of UBX1325
Uploaded: 2023-05-08T17:39:09+00:00
Description: David Xu, MD, asks Michael A. Singer, MD, about new 24-week data from the phase 2 ENVISION trial of UBX1325, a senolytic agent for patients with wet AMD.

2023 VBS Lifetime Mentorship Award

Aleksandra V. Rachitskaya, MD, FASRS, and Lisa C. Olmos de Koo, MD, MBA

Tackling Tough Pediatric Cases

Priya Vakharia, MD, and J. Peter Campbell, MD, MPH

International Surgery Highlights

Efrem Mandelcorn, MD, FRCSC

Discussing Wellness, VBS-Style

Kristen Nwanyanwu, MD, MBA, MHS, and Nicholas Farber, MD

K-Pro Combo Surgery

Kyle D. Kovacs, MD, and Jennifer I. Lim, MD

FOCUS on Fellows at VBS

Hong-Uyen Hua, MD, and Basil K. Williams, Jr, MD

Boosting LGBTQ Awareness in Retina

Jordan D. Deaner, MD and Vivienne Hau, MD, PhD

Working Around a PDS

Shilpa J. Desai, MD, and Gregory Lee, MD

2023 VBS Lifetime Achievement Award

Ehsan Rahimy, MD, and Allen C. Ho, MD

Debating Green Versus Blue